Company Biocorrx Inc Other OTC

Equities

US09073C1062

Healthcare Facilities & Services

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sector Other Healthcare Facilities & Services

Inactive Instrument

BioCorRx Inc., through its subsidiaries, develops and provides addiction treatment solutions for the treatment of substance use and other related disorders. Its Beat Addiction Recovery is a substance use disorder recovery program that typically includes its Cognitive Behavioral Therapy (CBT) modules along with peer support via mobile app along with medication prescribed by an independent treating physician under their discretion. The UnCraveRx Weight Loss Program is also a medication-assisted weight loss program that includes access to concierge on-demand wellness specialists, nutritionists, fitness experts, and personal support from behavioral experts. The Company, through its subsidiary, BioCorRx Pharmaceuticals Inc., is engaged in the development of BICX104, a subcutaneous implantable naltrexone pellet for the treatment of both opioid and alcohol use disorders. It is also engaged in the establishment of alcoholism and opioid addiction rehabilitation and treatment centers.

USD in Million	Weight	Weight	Delta
Distribution Rights 37.3 %	17.4 %	37.3 %	-10.83%
Project Support 29.0 %	70.4 %	29.0 %	-82.85%
Sales/Access 23.4 %	6.7 %	23.4 %	+45.21%
Membership/Program 10.4 %	5.4 %	10.4 %	-20.46%

USD in Million	2022	Weight	2023	Weight	Delta
United States 100.0 %	0	100.0 %	0	100.0 %	-58.31%

Managers	Title	Age	Since
Lourdes Felix CEO	Chief Executive Officer	56	12-09-30
Kent Emry CHM	Chairman	55	13-09-12
Louis Lucido PSD	President	75	19-02-28
Thomas Welch PRN	Corporate Officer/Principal	-	13-12-31
Dave de Csepel PRN	Corporate Officer/Principal	-	-
Balbir S. Brar PRN	Corporate Officer/Principal	87	-

Members of the board	Title	Age	Since
Louis Lucido PSD	President	75	19-02-28
Joe Galligan BRD	Director/Board Member	64	19-03-31
Luisa Ingargiola BRD	Director/Board Member	56	19-02-28
Lourdes Felix CEO	Chief Executive Officer	56	12-09-30
Kent Emry CHM	Chairman	55	13-09-12
Katherine Beebe-DeVarney BRD	Director/Board Member	63	Feb. 07

	Vote	Quantity	Free-Float	Total Float
Stock A	0	160,000	0	39.01 %
Stock B	1	8,815,454	3,438,872 ( 39.01 %)
Stock C	0	80,000	0

Name	Equities	%	Valuation
BICX Holding Co. LLC 25.90 %	2,227,575	25.90 %	2 M $
Louis Lucido 20.05 %	1,724,444	20.05 %	2 M $
Joe Galligan 15.73 %	1,352,382	15.73 %	1 M $
Kent Emry 1.864 %	160,263	1.864 %	143 435 $
Brady Granier 1.070 %	91,986	1.070 %	82 327 $
Lourdes Felix 0.9349 %	80,395	0.9349 %	71 954 $
Luisa Ingargiola 0.5796 %	49,843	0.5796 %	44 609 $
Thomas Welch 0.3533 %	30,383	0.3533 %	27 193 $
Harsha Murthy 0.2293 %	19,719	0.2293 %	17 649 $

Name	Equities	%	Valuation
Kent Emry 25.00 %	40,000	25.00 %	35 800 $
Brady Granier 25.00 %	40,000	25.00 %	35 800 $
Thomas Welch 25.00 %	40,000	25.00 %	35 800 $
Lourdes Felix 25.00 %	40,000	25.00 %	35 800 $

Name	Equities	%	Valuation
Lourdes Felix 12.50 %	10,000	12.50 %	8 950 $
Brady Granier 12.50 %	10,000	12.50 %	8 950 $
Kent Emry 12.50 %	10,000	12.50 %	8 950 $
Thomas Welch 12.50 %	10,000	12.50 %	8 950 $

BioCorRx, Inc.

2390 East Orangewood Avenue Suite 500

92806, Anaheim

+714 462 4880

http://www.biocorrx.com

Healthcare

Healthcare Services

Healthcare Providers & Services

Healthcare Facilities & Services

Other Healthcare Facilities & Services

	1st Jan change	Capi.
CVS HEALTH CORPORATION	-14.92%	84.68B
HCA HEALTHCARE, INC.	+13.30%	81.12B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+11.62%	29.4B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-12.71%	16.73B
FRESENIUS SE & CO. KGAA	-3.06%	16.36B
QUEST DIAGNOSTICS INCORPORATED	-2.63%	14.92B
PURE HEALTH HOLDING	-31.75%	11.77B
FRESENIUS MEDICAL CARE AG	-1.42%	11.72B
DAVITA INC.	+27.44%	11.71B

Other Healthcare Facilities & Services